Insights+: COVID-19 Healthcare News Monthly Updates - July 2020
- Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
- The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
- PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
Jul 30, 2020 | Clinical Trial
74. Sanofi and GSK Sign an Agreement with the UK Government to Supply ~60M Doses of COVID-19 Vaccine
Jul 29, 2020 | Collaboration
73. UK's Recovery Continues to Test Roche's Tocilizumab in COVID-19
Jul 29, 2020 | Clinical Trial
72. Roche's Actemra/RoActemra Fails in COVID-19 Trial
Jul 29, 2020 | Clinical Trial
71. Green Cross GC5131A Receives the Regulatory Approval for P-II Trial for COVID-19
Jul 29, 2020 | Regulatory
70. Relief's RLF-100 (aviptadil) Receives the US FDA's Expanded Access Protocol to Treat Respiratory Failure in COVID-19
Jul 29, 2020 | Regulatory
Jul 28, 2020 | Regulatory
Jul 28, 2020 | Clinical Trial
67. Gilead's Veklury (Remdesivir) Health Canada's Marketing Authorization with Conditions (NOC/c) to Treat COVID-19
Jul 28, 2020 | Regulatory
66. Three Pharma Companies Launch Favipiravir to Treat COVID-19 in India
Jul 27, 2020 | Launch
65. Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer
Jul 27, 2020 | Collaboration
64. AI Therapeutics Reports Initiation of P-II Trial of LAM-002A (apilimod dimesylate) for COVID-19 Patients
Jul 27, 2020 | Clinical Trial
63. Zydus to Initiate Clinical Study of Desidustat in Patients with Chemotherapy-Induced Anemia (CIA)
July 24, 2020 | Clinical Trial
62. Glenmark Report Results of FabiFlu (favipiravir) in P-III Clinical Study for Patients with Mild to Moderate COVID-19
Jul 27, 2020 | Clinical Trial
61. The UK Government to Launch AbC-19 Lateral Flow Free Finger-Prick Test for COVID-19
Jul 27, 2020 | Launch
60. Mylan Launches Remdesivir Under the Brand Name Desrem for COVID-19 in India
Jul 27, 2020 | Launch
59. Pfizer and BioNTech Elicits Strong T-cell Response in P-I/II Study Against COVID-19
Jul 27, 2020 | Clinical Trial
Jul 27, 2020 | Clinical Trial
57. Quest Diagnostic Receives the US FDA's First EUA for Sample Pooling in COVID-19
Jul 20, 2020 | Diagnostic
56. Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea
Jul 20, 2020 | Clinical Trial
55. Zydus Initiates Adaptive P-I/II Clinical Study Evaluating its ZyCoV-D Against COVID-19 in India
Jul 16, 2020 | Clinical Trial
54. Novartis Launches Zero Profit Portfolio for Symptomatic Treatment of COVID-19
Jul 16, 2020 | Launch
53. AstraZeneca and the University of Oxford to Share Positive News on its COVID-19 Vaccine Imminently
Jul 15, 2020 | Collaboration
52. 3M Collaborates with MIT to Develop Paper-Based Diagnostic Test for COVID-19
Jul 13, 2020 | Collaboration
51. Moderna to Commence Late-stage COVID-19 Vaccine Trial on 27 July, 2020
Jul 13, 2020 | Clinical Trial
50. The International Fencing Federation (FIE) Reports the Global COVID-19 Support Plan
July 13, 2020 | Launch
Jul 12, 2020 | Regulatory
48. The Zimbabwe Government to Launch US $10M COVID-19 Relief Package
Jul 11, 2020 | Launch
Jul 10, 2020 | Regulatory
46. AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics
Jul 10, 2020 | Collaboration
45. Cipla Launches Cipremi at $53.34 per Vial in India
Jul 10, 2020 | Launch
44. The Health Ministry of Kyrgyzstan Reports Supply of Avifavir an Antiviral Drug form Russia
Jul 09, 2020 | Regulatory
43. Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M
Jul 08, 2020 | Clinical Trial
42. Angion Commences P-II Study of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia in Brazil
Jul 08, 2020 | Clinical Trial
41. The European Commission Signs an Agreement with Roche and Merck to Supply their COVID-19 Therapies in EU
Jul 09, 2020 | Collaboration
40. GSK and Medicago to Initiate P-I Trial of Plant-Based COVID-19 Vaccine in July 2020
Jul 08, 2020 | Clinical Trial
39. Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M
Jul 08, 2020 | Collaboration
38. Innovation Pharmaceuticals Reports Results Brilacidin in COVID-19 Clinical Trial
Jul 07, 2020 | Clinical Trial
37. Reven Reports Publication of Two COVID-19 Articles for RJX Platform
Jul 07, 2020 | Regulatory
36. Emergent Signs a Five-Year Manufacturing Services Agreement with Janssen for Ad26.COV2-S to Treat COVID-19
Jul 07, 2020 | Collaboration
35. Constant Therapeutics' TXA127 will be Evaluated in P-II Trial for COVID-19 Patients
Jul 07, 2020 | Clinical Trial
34. Sinovac's P-III COVID-19 Trial Receives the Brazilian Regulator Approval
Jul 07, 2020 | Regulatory
33. Nasus Pharma Reports Results of TaffiX as a Intranasal Antiviral Protection Against SARS-CoV-2
Jul 07, 2020 | Clinical Trial
32. Mylan Receives EUA Approval for its Remdesivir to Treat COVID-19
Jul 07, 2020 | Regulatory
31. Diffusion Pharmaceuticals Reports IND Submission for P-Ib/IIb COVID-19 Clinical Program with TSC to the US FDA
Jul 07, 2020 | Clinical Trial
30. Novavax to Receive $1.6B Funds from the US
Jul 07, 2020 | Grants
29. Aboundbio Signs an Agreement with SaudiVax for COVID-19
Jul 07, 2020 | Collaboration
28. Hepion Pharmaceuticals Reports Preclinical Results of CRV431 for Treating COVID-19
Jul 07, 2020 | Clinical Trial
27. Therapeutic Solution Reports Submission of Publication of Preclinical Data on StemVac for Supporting COVID-19 Indication
Jul 07, 2020 | Clinical Trial
26. Regeneron with its Partner NIAID Report the Initiation of P-III Trial to Evaluate REGN-COV2 for Treatment and Prevention of COVID-19
Jul 06, 2020 | Clinical Trial
25. Mylan's Remdesivir Lyophilized Powder for Injection Receives the DCGI Accelerated Approval for Restricted Emergency Use in COVID-19 Patients in India
Jul 06, 2020 | Regulatory
24. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Jul 03, 2020 | Clinical Trial
23. Sanofi and Regeneron's Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US
Jul 03, 2020 | Clinical Trial
22. Moderna Reports the Enrollment of P-II Trial for its mRNA-1273 to Treat COVID-19
Jul 03, 2020 | Clinical Trial
21. Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19
Jul 02, 2020 | Clinical Trial
20. Dr. Reddy's and GRA Collaborate with Fujifilm for Avigan (favipiravir) to Treat COVID-19 Outside Japan
Jul 02, 2020 | Collaboration
19. Pfizer and BioNTech Report Results of BNT162b1 mRNA-Based Vaccine in P-I/II Study Against COVID-19
Jul 02, 2020 | Clinical Trial
18. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Jul 03, 2020 | Clinical Trial
17. Sanofi and Regeneron's Kevzara (sarilumab) Fails in P-III Study for Patients with COVID-19 in the US
Jul 02, 2020 | Clinical Trial
16. Phase II Study of MRx-4DP0004 in Patients Hospitalized with COVID-19 Open for Enrolment
Jul 02, 2020 | Clinical Trial
15. Regulatory Authorities Step Up Cooperation in Connection with COVID-19
Jul 02, 2020 | Regulatory
14. Austria Donates 2M to CEPI to Support COVID-19 Vaccine Programmes
Jul 02, 2020 | Grant
13. Liminal BioSciences Joins CoVIg Plasma Alliance to Develop New COVID-19 Therapy
Jul 02, 2020 | Collaboration
12. Biophytis Receives FDA IND Clearance for COVA, a P-II/III Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure
Jul 02, 2020 | Clinical Trial
11. EUSA Receives the US FDA Approval of P-III Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome
Jul 02, 2020 | Clinical Trial
10. Moderna Faces Delay in its COVID-19 Vaccine Trial
Jul 02, 2020 | Clinical Trial
9. Anivive Initiates Two Pre-Clinical Studies of GC376 for the Treatment of COVID-19
Jul 02, 2020 | Clinical Trial
8. MediciNova Announces Opening of IND for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19
Jul 01, 2020 | Clinical Trial
7. GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 P-II Trial in the US
Jul 01, 2020 | Regulatory
6. New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19
Jul 01, 2020 | Clinical Trial
5. International Regulators Provide Guiding Principles for COVID-19 Clinical Trials
Jul 01, 2020 | Regulatory
4. FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation
Jul 01, 2020 | Clinical Trial
3. Inimmune Awarded $2M SBIR to Advance Vaccine Technologies
Jul 01, 2020 | Grant
Jul 01, 2020 | Clinical Trial
1. FAMHP Facilitates and Supports the Development of COVID-19 Treatments and Vaccines
Jul 01, 2020 | Regulatory
Related Post : Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates – March 2020
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com